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THYMINE AND URACIL METABOLISM IN THE EPIDERMIS*
HOWARD P. BADEN, M.D.
As compared with the viable epidermis, the
stratum corneuin contains very small amounts
of both DNA and RNA (1, 2, 3, 4). This decrease
in nucleic acid content is correlated with the
disappearance of nuclei and ribosomes which
occurs at the junction of the granular layer and
stratum corneum. Enzymes necessary for the
hydrolysis of these cellular organdIes have been
found in the epidermis (5, 6, 7, 8, 9), but the
purine and pyrimidine bases which are major
components of nucleic acids are either absent or
are present in trace quantities (1, 4). Some purine
metabolites have been found in the stratum
corneum (1, 4), but no data is available on the
pyrimidines. Since certain disorders of the epi-
dermis such as psoriasis are associated with
abnormalities of nucleic acid turnover (10, 11,
12, 13), it was felt that more detailed information
on the metabolism of pyrimidines by the epi-
dermis would be of importance. The purpose of
this report is to describe the fate of thymidine
and uridine incorporated into epidermal nucleic
acids in vivo, and to investigate the catabolism
of their respective pyrimidine bases by epidermis
in vitro.
MATERIALS
Methyl tritiated thymidine (8 c/mmole),
thymine-2-C'4 (11 mc/mmole) and uridine-2-C'4
(25 mc/mmole) were purchased from New England
Nuclear Corp., and dihydrothymine (PITT),
dihydrouracil (DHU), B-alanine, and B-aminoiso-
butyric acid (BAIB) from the California Bio-
chemical Corp. The B-ureidoisobutyric (BUlB)
and B-ureidopropionic acid (BUP) were prepared
as described by Fink et al (14).
METHODS
Thymidine and uridine nietabolism in vivo
One hundred c of labelled thymidine or 10 ZC of
uridine were injected intraperitoneally into
hairless mice (hr, Jackson Memorial Lab.) and two
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1.0 cm in diameter full thickness skin biopsy
specimens obtained at varying intervals. The
biopsy specimens were heated at 50° C for 1
minute and the epidermis separated by gentle
scraping with a scalpel. The epiderrnal tissue was
homogenized at 0° C in .25 M perchioric acid, the
homogenate centrifuged and the precipitate
washed two times with the same solvent. The
combined supernatants (the cold acid extract)
contained the nucleosides and their degradation
products. The pellets were then treated with 10%
perchioric acid at 80° C for 15 minutes to extract
the nucleic acids (2). The precipitates were washed
with ethanol and ether (3 to 1), and ether to
remove lipid and the pellets consisting largely of
proteins were then dried.
Aliquots of the hot and cold perchloric acid
extracts were pipetted into 1/2 ml of 1 M hyamine
and 15 ml of dioxane with 4 gins 2, 5-diphenyl-
oxazole, 250 mg 1, 4-bis-2(5-phenyloxozolyl)-
benzene and 100 gin naphthalene per liter (15) and
the radioactivity assayed in a liquid scintillation
counter. Correction for differences in quenching
was made by the addition of an internal standard
and the data expressed as cpm for two 1 cm biopsy
specimens. Radioactivity in the ethanol and ether
extracts was determined as above, while that in
the protein pellet by a combustion technic (16). A
second aliquot of the cold acid extract was neu-
tralized with potassium hydroxide, centrifuged
and the supernatant concentrated on a rotary
evaporator. Following the addition of carrier
thymine and uracil ascending paper chromatogra-
phy was done in isopropyl alcohol, acetic acid and
water (50:25:25: v/v/v) (14). The location of the
pyrimidines was identified by examining the papers
under ultraviolet light and then the papers were
cut and the radioactivity eluted with water. The
washings were concentrated and counted as de-
scribed above.
Two biopsy specimens 1.9 cm in diameter were
obtained from mice injected twelve days pre-
viously with labelled thymidine. The epidermis
was separated from one with heat while the other
was stripped with cellophane tape to remove the
stratum corneum. Radioactivity was determined
in the epidermis and cellophane strippings by the
combustion technic (16).
DHT and DHU catabolism by epidermis in vitro
Guinea pig skin was epilated with wax (17) and
biopsy specimens 1.9 cm in diameter were obtained
with a dermal punch. Specimens containing the
epidermis and a thin layer of dermis were prepared
from the biopsy material with a Stadie Riggs
microtome (17). Slices of liver were prepared
similarly. Ten slices were incubated in 10 ml of
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FIG. 1. Radioactivity in the epidermis following the injection of labelled thymidine. 0—0 DNA,
•—• cold acid extract.
Krebs' Ringer phosphate with either .02M DHT
or DHU at 370 C with constant shaking for 2 hours.
The controls used were heated tissue with sub-
strate, tissue with no substrate and substrate
without tissue. DHT and DHTJ were used instead
of thymine and uracil since they have been shown
to be better substrates for measuring the de-
gradative pathways of the pyrimidine bases (14).
The incubation mixture was adjusted to pH 5,
heated for 5 minutes in a boiling water bath and
homogenized at 0° C. The suspension was clarified
by centrifugation and the supernatant dried in a
rotary evaporator. This residue was extracted
with 6N hydrochloric acid in acetone (1/20) and
ascending chromatography done as described
above. DHT, BUlB, BAIB, DHU, BUP and
B-alanine were identified as described by Fink
et al (14), The amount present was estimated
visually on an arbitrary scale by the intensity of
color developed with a known aliquot of the
sample.
Decarboxylation of thymine by epidermis in vitro
Epidermis was separated from four 1.0 cm in
diameter biopsy specimens with collagenase (17),
and incubated in 3 ml of Krebs' Ringer phosphate
with 5 uc of thymine-2-C14 for 2 hours at 37° C.
The reaction was carried out in sealed Warburg
flasks with filter paper saturated with 1 N po-
tassium hydroxide in the center well to collect the
evolved C"02. Four 1.0 cm in diameter slices of
liver prepared with a Stadie Riggs microtome
were similarly incubated. The reaction was
stopped by addition to the incubation mixture of
.2 ml of 1 N sulfuric acid from the side well. The
papers were removed and counted in a scintillation
counter (18).
RESULTS
Following the injection of mice with labelled
thymidine there is a peak of radioactivity in DNA
at 24 hours, and then a slow decrease to 50% of
the maximum value in about six days (Figure 1).
The radioactivity in the cold acid extract drops
more rapidly and remains low even while the
activity in DNA continues to decrease. Radio-
activity in the cold acid extract of blood which
represents catabolites of the pyrimidines formed
in the liver (19) shows the same decrease with
time as the epidermis. Some of the radioactivity
in the cold acid extract of epidermis may have
resulted from these catabolites having been de-
posited in the epidermis. Chromatography of the
epidermal cold acid extracts showed that la-
belled thymine accounted for 25 to 50% of the
total radioactivity. The remainder of the radio-
activity occurred in a number of different posi-
tions on the chromatogram, but could not be
identified more precisely because of the low
levels of radioactivity. The amount of radio-
activity found in fat and protein was less than
that in the cold acid extract at all time intervals.
The distribution of radioactivity in the epi-
dermis 12 days after injection (Table I) indicates
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that most is found in the viable epidermis, while
that in the stratum corneum represents less than
5% of that originally incorporated into DNA.
Following the injection of hairless mice with
labelled uridine, the pattern of labelling in the
hot and cold perchloric acid extracts is similar
to that observed in the thymidine experiments
(Figure 2).
Chromatography of extracts from epidermis
showed no thymine, uracil, DHT, DHU, BUlB,
BlIP, BAIB, or B—alanine. As shown in Tables
II and III there is no evidence of catabolism of
T0 a Cpm
Percent of
radioactivitypresent in DNA
at 24 hours
Strippings
Whole Epidermis
75
456
4%
25%
TABLE II
Catabolism of DHT by epidermis and liver
BUlB BAIB
Liver Slices + DHT
Liver Slices (heated) +
DIIT
Skin Slices + DHT
Skin Slices (heated) +
DHT
DHT
Skin Slices
10+
1+
1+
1+
1+
0
10+
0
0
0
0
0
BUP $-ALANINE
Liver Slices + DIIU
Liver Slices (heated) +
DHU
Skin Slices + DHU
Skin Slices (heated) +
DHU
Dill
Skin Slices
10+
1+
1+
1+
1+
0
10+
0
0
0
0
0
TABLE IV
Decarboxylation of thymine-P-C14
C"O evolved (cpm)
Skin Slices
Skin Slices (heated)
Liver Slices
Liver Slices (heated)
0
0
2,000
100
DHT or Dill following the incubation with epi-
dermis. Furthermore, there is no decarboxylation
of thymine-2-C'4 (20) by guinea pig epidermis
(Table IV).
DISCUSSION
Autoradiographs of skin from animals and
humans injected with radioactive thymidine
show that the label is incorporated first into the
nuclei of the basal layer (10, 11, 21). As cell divi-
sion occurs, the radioactivity is observed in the
upper layers of the viable epidermis, but never
appears in the stratum corneum (21). This sug-
gests that the nucleoside, or the free pyrimidine,
is not retained in cells as the latter ascend from
the maiphigian to horny layer. Since the deposi-
tion of silver grains depends on the level of radio-
activity within a given site, there is one possible
way thymine or thymidine still could be present
in the stratum corneum and not be detected.
This involves the redistribution of the labelled
compounds following hydrolysis of nucleic acids.
The data in this study indicate that this hypothe-
sis is not tenable. The cold acid extract of epi-
dermis which would contain labelled thymine
and thymidine shows no increase in radioactivity
during the phase when radioactivity in DNA is
decreasing.
The presence of several unidentified radioactive
TABLE III
Catabolism of DHU by epidermis and liver
DAYS
FIG. 2. Radioactivity in the epidermis follow-
ing the injection of labelled uridine. 0—0 RNA,
•—• cold acid extract.
TABLE I
Localization of radioactivity in the epidermis
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FIG. 3. Catabolism of thymine
spots in the cold acid extracts could result from
circulating metabolites deposited in the epidermis
or epidermal metabolism of thymine. The cata-
bolic pathways for thyrnine are shown in Figure
3; those for uracil are similar but involve the
formation DHU, BlIP and B-alanine. Failure to
demonstrate any of these pathways suggest that
no metabolism of thymine or uracil occurs in the
epidermis.
There are several alternate hypotheses for the
handling of pyrimidines by the epidermis: (1)
They are recycled into nucleic acids and remain
trapped in the viable epidermis. (2) They diffuse
rapidly through the stratum corneum and are
lost at the surface of the skin. (3) They are reab-
sorbed into the systemic circulation.
The phenomenon of recycling of thymine and
uracil is unknown in other tissues. The amount of
radioactivity in nucleic acids would not have
dropped in the in vivo experiments if the pyrimi-
dines had been reutilized for nucleic acid syn-
thesis. Furthermore, the half life of DNA (T )
corresponds closely to that of epidermal cells as
measured by other techniques (10, 21).
Rapid diffusion of pyrimidines through the
stratum corneum seems most unlikely consider-
ing the known low permeability of this structure.
Other epidermal metabolites such as uric acid,
amino acids, and urocanic are not lost in this
manner (22).
The most tenable hypothesis to explain our
observations is that the pyrimidines are reab-
sorbed into the circulation. There is good evi-
dence for the reabsorption of purine bases or their
catabolites from the epidermis. It has been shown
that patients with active psoriasis have an in-
creased pool size and urinary excretion of uric
acid (23). The magnitude of the uric acid pool
follows the amount of scaling and returns to
normal when the disease is in remission. In these
patients the number of cells lost per day, and
hence the amount of nucleic acids metabolized,
may be 50 times normal. A markedly increased
reabsorption of purines or purine catabolites
would explain an increased pool of uric acid.
Although it appears that the principle way
pyrimidines are lost by the epidermis is reabsorp-
tion into the circulation, a small amount may
be shed with the stratum corneum. This is indi-
cated by the presence of radioactivity in cello-
phane strippings of the epidermis. Since this
represents less than 5% of radioactivity origi-
nally incorporated into DNA it must be regarded
as a minor pathway.
SUMMABY
Hairless mice have been injected with radio-
active thymidine and uridine and the pattern of
labelling in the epidermis investigated. The data
suggest that pyrimidine bases released following
the hydrolysis of nucleic acids are reabsorbed
into the systemic circulation. This is confirmed
by the failure to observe any degradation of
thymine and uracil by epidermal tissue. Small
amounts of these bases may be lost in the stratum
corneum, but this represents a minor pathway.
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